Frankfurt - Delayed Quote EUR
Syndax Pharmaceuticals, Inc. (1T3.F)
11.50
+0.10
+(0.88%)
At close: April 29 at 8:02:55 AM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| GALLAGHER NEIL Officer | Sale | Feb 10, 2025 | 85,095 |
| GOLDAN KEITH ALAN Chief Financial Officer | Sale | Feb 10, 2025 | 90,746 |
| HUBER MARTIN H JR Director | Stock Award(Grant) | Feb 5, 2025 | 74,000 |
| JARRETT A JENNIFER Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
| KATKIN KEITH A Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
| LEGAULT PIERRE Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
| METZGER MICHAEL A Chief Executive Officer | Conversion of Exercise of derivative security | Mar 14, 2025 | 306,195 |
| MEURY WILLIAM Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
| PODLESAK DENNIS G Director | Stock Award(Grant) | Feb 5, 2025 | 191,763 |
| RIZO ALEKSANDRA M.D. PH.D. Director | Stock Award(Grant) | Feb 5, 2025 | 25,000 |
Related Tickers
AVU0.F Adverum Biotechnologies, Inc.
2.5000
-0.79%
1JK.F Apellis Pharmaceuticals, Inc.
15.14
+3.73%
69C.MU Tvardi Therapeutics Inc. R
19.74
+18.77%
F6T.F Fate Therapeutics, Inc.
1.0760
-2.09%
THRD Third Harmonic Bio, Inc.
5.15
0.00%
SION Sionna Therapeutics, Inc.
12.04
0.00%
CNTA Centessa Pharmaceuticals plc
13.72
-0.22%
LYEL Lyell Immunopharma, Inc.
0.4321
-2.02%
UPB Upstream Bio, Inc.
8.98
+2.28%
VRCA Verrica Pharmaceuticals Inc.
0.4597
-0.95%